Yes expectation of ongoing positive data should see the sp correlate with that in an upward trajectory.
PRR has some 14000 shareholders and its obvious that the great bulk of these are sitting quietly awaiting final outcomes. IMO the day to day trading is a variety of traders and new buyers wanting to stay longer term.
In spite of the large number number of holders who are sitting waiting, it is still a very liquid stock and that is attractive to traders and investors alike. PRR will IMO continue to be a stock of great interest during its journey to success.
I also await a persistent uptrend. Big Pharma possibly already realises that immunotherapy is the way forward with cancer and they will eventually be all over the stocks that are involved.
Just my own opinions. dyor.
impact of time in cvac immunotherapy, page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $537.4M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.3¢ | 36.5¢ | $1.060M | 2.841M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 48648 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 13814 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |